20 April 2023
Thanks to the generosity of our supporters, Addenbrooke’s has become the first hospital in the world to offer a brand new body-worn device to Parkinson’s disease inpatients, significantly and quickly improving their movement.
The new CUE1 device, developed in Cambridge, is commonly worn on the sternum and delivers specialised patterns of vibrating and pulses, helping to improve the patients motor skills, walking parameters and reduces falls.
Addenbrooke’s Charitable Trust (ACT) is proud to have funded 10 of these life changing devices for the hospital, made possible by the donations and fundraising of our amazing supporters.
ACT Chief Executive, Shelly Thake, said: “We are extremely pleased to be able to support this trial and bring the hope of greater movement to Parkinson’s patients, and a reduction in falls. We wish all involved good luck with it.”Return to news